Login / Signup
Kaori Miyana
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
2025
2016
Top Topics
2025
2016
Adverse Drug
2025
2016
Emergency Department
Top Venues
Pediatrics international : official journal of the Japan Pediatric Society
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Kaori Miyana
,
Akihiko Ishiyama
,
Yoshihiko Saito
,
Ichizo Nishino
Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.
Pediatrics international : official journal of the Japan Pediatric Society
64 (1) (2022)